Bimatoprost
Sold as Lumigan, Latisse, Durysta, Zolymbus. Every FDA application for this active ingredient: 5 branded and 20 generic.
- First approved: Mar 16, 2001
- Applications: 25
- New uses approved: 2
- Complete response letters: 0
Applications
NDAs, BLAs and generic ANDAs for this ingredient, oldest first; each opens its full history| Approved | Application | Sponsor | Supplements | Marketing |
|---|---|---|---|---|
| Mar 16, 2001 | LumiganNDA 21275 · New molecular entity | Abbvie | 17 | Discontinued |
| Dec 24, 2008 | LatisseNDA 22369 · New formulation or manufacturer | Abbvie | 11 | Marketed |
| Aug 31, 2010 | LumiganNDA 22184 · New formulation or manufacturer | Abbvie | 7 | Marketed |
| Dec 1, 2014 | BimatoprostANDA 201894 | Apotex | 3 | Discontinued |
| Feb 20, 2015 | BimatoprostANDA 203991 | Lupin | 4 | Discontinued |
| May 5, 2015 | BimatoprostANDA 202565 | Sandoz | 2 | Marketed |
| Jul 20, 2015 | BimatoprostANDA 90449 | Apotex | 3 | Marketed |
| Apr 19, 2016 | BimatoprostANDA 202719 | Sandoz | 3 | Marketed |
| Oct 9, 2018 | BimatoprostANDA 203051 | Hikma | 2 | Discontinued |
| Nov 8, 2018 | BimatoprostANDA 203299 | Hikma | 0 | Discontinued |
| Mar 22, 2019 | BimatoprostANDA 210126 | Gland | 2 | Marketed |
| Apr 12, 2019 | BimatoprostANDA 210263 | Alembic | 2 | Marketed |
| Jun 19, 2019 | BimatoprostANDA 207601 | Somerset Theraps LLC | 3 | Marketed |
| Jan 21, 2020 | BimatoprostANDA 210515 | Alembic | 2 | Marketed |
| Mar 4, 2020 | DurystaNDA 211911 · New dosage form | Abbvie | 2 | Marketed |
| Sep 8, 2020 | BimatoprostANDA 202505 | Micro Labs | 0 | Marketed |
| Oct 6, 2022 | BimatoprostANDA 205537 | Eugia Pharma | 0 | Marketed |
| Mar 17, 2025 | BimatoprostANDA 218196 | Mankind Pharma | 0 | Marketed |
| Sep 9, 2025 | ZolymbusNDA 217307 · New dosage form | Thea Pharma | 0 | Marketed |
| Sep 22, 2025 | BimatoprostANDA 217289 | Amneal | 0 | Marketed |
| — | BimatoprostANDA 200487 | Sandoz | 0 | Discontinued |
| — | BimatoprostANDA 203056 | Sandoz Inc | 0 | Discontinued |
| — | BimatoprostANDA 203404 | Apotex Inc | 0 | Discontinued |
| — | BimatoprostANDA 204638 | Micro Labs Ltd India | 0 | Discontinued |
| — | BimatoprostANDA 209797 | Gland Pharma Ltd | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Drugs@FDA